Laura Ferrer‐Font

506 total citations
23 papers, 338 citations indexed

About

Laura Ferrer‐Font is a scholar working on Molecular Biology, Biophysics and Immunology. According to data from OpenAlex, Laura Ferrer‐Font has authored 23 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Biophysics and 5 papers in Immunology. Recurrent topics in Laura Ferrer‐Font's work include Single-cell and spatial transcriptomics (12 papers), Immune Cell Function and Interaction (5 papers) and Cell Image Analysis Techniques (5 papers). Laura Ferrer‐Font is often cited by papers focused on Single-cell and spatial transcriptomics (12 papers), Immune Cell Function and Interaction (5 papers) and Cell Image Analysis Techniques (5 papers). Laura Ferrer‐Font collaborates with scholars based in New Zealand, Spain and United States. Laura Ferrer‐Font's co-authors include Kylie M. Price, Johannes U. Mayer, María C. Jaimes, Christophe Pellefigues, Carles Arús, Ana Paula Candiota, Katherine R. Pilkington, Ian F. Hermans, Silvia Lope‐Piedrafita and Jonathan M. Irish and has published in prestigious journals such as eLife, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Gut Microbes.

In The Last Decade

Laura Ferrer‐Font

20 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Ferrer‐Font New Zealand 9 209 120 55 51 42 23 338
Nalin Leelatian United States 11 258 1.2× 143 1.2× 55 1.0× 17 0.3× 54 1.3× 24 440
Reema Baskar United States 7 180 0.9× 131 1.1× 38 0.7× 26 0.5× 12 0.3× 8 317
Mingyu Yang China 5 519 2.5× 119 1.0× 86 1.6× 54 1.1× 30 0.7× 9 626
Sophia Müller‐Dott Germany 6 402 1.9× 126 1.1× 36 0.7× 13 0.3× 21 0.5× 9 625
Petr Tauš Czechia 3 182 0.9× 91 0.8× 13 0.2× 15 0.3× 19 0.5× 5 336
Jana M. Braunger Germany 3 227 1.1× 95 0.8× 23 0.4× 11 0.2× 17 0.4× 5 385
Carla Rossana Scalia Italy 8 171 0.8× 43 0.4× 49 0.9× 19 0.4× 9 0.2× 9 291
Erik L. Bao United States 10 314 1.5× 71 0.6× 33 0.6× 12 0.2× 53 1.3× 14 538
Stephan Grein Germany 8 100 0.5× 64 0.5× 16 0.3× 14 0.3× 23 0.5× 14 251
Bonnie Bullock United States 9 223 1.1× 303 2.5× 27 0.5× 18 0.4× 12 0.3× 9 579

Countries citing papers authored by Laura Ferrer‐Font

Since Specialization
Citations

This map shows the geographic impact of Laura Ferrer‐Font's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Ferrer‐Font with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Ferrer‐Font more than expected).

Fields of papers citing papers by Laura Ferrer‐Font

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Ferrer‐Font. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Ferrer‐Font. The network helps show where Laura Ferrer‐Font may publish in the future.

Co-authorship network of co-authors of Laura Ferrer‐Font

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Ferrer‐Font. A scholar is included among the top collaborators of Laura Ferrer‐Font based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Ferrer‐Font. Laura Ferrer‐Font is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mair, Florian, et al.. (2024). Combinatorial antibody titrations for high‐parameter flow cytometry. Cytometry Part A. 105(5). 388–393. 1 indexed citations
2.
Ferrer‐Font, Laura, et al.. (2024). Panel Design and Optimization for Full Spectrum Flow Cytometry. Methods in molecular biology. 2779. 99–124. 3 indexed citations
3.
Ferrer‐Font, Laura, et al.. (2024). Immunophenotyping challenging tissue types using high-dimensional full spectrum flow cytometry. Methods in cell biology. 186. 51–90. 1 indexed citations
4.
Ferrer‐Font, Laura, et al.. (2024). The consequence of mismatched buffers in purity checks when spectral cell sorting. Cytometry Part A. 105(12). 909–914. 1 indexed citations
5.
Ferrer‐Font, Laura, et al.. (2024). SingletSeeker: An unsupervised clustering approach for automated singlet discrimination in cytometry. Cytometry Part B Clinical Cytometry. 108(5). 378–391.
6.
Gravano, David M., et al.. (2023). Shared resource lab ( SRL ) strategies for supporting high‐dimensional cytometry data analysis. Cytometry Part A. 103(12). 947–952.
7.
Ferrer‐Font, Laura, et al.. (2023). Ensuring Full Spectrum Flow Cytometry Data Quality for High‐Dimensional Data Analysis. Current Protocols. 3(2). e657–e657. 7 indexed citations
8.
Ferrer‐Font, Laura, R. J. Anderson, Benjamin J. Compton, et al.. (2022). Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect. OncoImmunology. 11(1). 2081009–2081009. 6 indexed citations
9.
Ferrer‐Font, Laura, Alfonso Schmidt, Franca Ronchese, & Kylie M. Price. (2022). A guideline for the appropriate recognition of shared resource laboratories in publication. Cytometry Part A. 103(3). 193–197. 1 indexed citations
10.
Farrand, Kathryn J., Lauren E. Holz, Laura Ferrer‐Font, et al.. (2022). Using Full‐Spectrum Flow Cytometry to Phenotype Memory T and NKT Cell Subsets with Optimized Tissue‐Specific Preparation Protocols. Current Protocols. 2(7). e482–e482. 7 indexed citations
11.
Soldevila, Berta, et al.. (2021). Reference Intervals of Thyroid Function Tests Assessed by Immunoassay and Mass Spectrometry in Healthy Pregnant Women Living in Catalonia. Journal of Clinical Medicine. 10(11). 2444–2444. 8 indexed citations
12.
Ferrer‐Font, Laura, Alfonso Schmidt, Sally C. Chappell, et al.. (2020). High-dimensional analysis of intestinal immune cells during helminth infection. eLife. 9. 21 indexed citations
13.
Ferrer‐Font, Laura, et al.. (2020). Panel Design and Optimization for High‐Dimensional Immunophenotyping Assays Using Spectral Flow Cytometry. Current Protocols in Cytometry. 92(1). e70–e70. 81 indexed citations
14.
Ferrer‐Font, Laura, et al.. (2020). High‐Dimensional Data Analysis Algorithms Yield Comparable Results for Mass Cytometry and Spectral Flow Cytometry Data. Cytometry Part A. 97(8). 824–831. 33 indexed citations
15.
Ferrer‐Font, Laura, Jordi Vilardell, Maria Plana, et al.. (2017). Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice. Pharmaceuticals. 10(1). 24–24. 34 indexed citations
16.
Ferrer‐Font, Laura, Silvia Lope‐Piedrafita, Margarida Julià‐Sapé, et al.. (2017). Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment. Metabolites. 7(2). 20–20. 16 indexed citations
17.
Ferrer‐Font, Laura, Silvia Lope‐Piedrafita, Margarida Julià‐Sapé, et al.. (2017). Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide. NMR in Biomedicine. 30(9). 25 indexed citations
18.
Ferrer‐Font, Laura, Ana Paula Candiota, Rui V. Simões, et al.. (2016). Improving Ribosomal RNA Integrity in Surgically Resected Human Brain Tumor Biopsies. Biopreservation and Biobanking. 14(2). 156–164. 6 indexed citations
19.
Ferrer‐Font, Laura, et al.. (2015). Protein Kinase CK2 Content in GL261 Mouse Glioblastoma. Pathology & Oncology Research. 22(3). 633–637. 5 indexed citations
20.
Barroso, Emma, Rosalía Rodríguez‐Rodríguez, Matilde R. Chacón, et al.. (2015). PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(5). 1049–1058. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nalin Leelatian Breakdown of academic impact, for papers by Reema Baskar Breakdown of academic impact, for papers by Mingyu Yang Breakdown of academic impact, for papers by Sophia Müller‐Dott Breakdown of academic impact, for papers by Petr Tauš Breakdown of academic impact, for papers by Jana M. Braunger Breakdown of academic impact, for papers by Carla Rossana Scalia Breakdown of academic impact, for papers by Erik L. Bao Breakdown of academic impact, for papers by Stephan Grein Breakdown of academic impact, for papers by Bonnie Bullock
Rankless by CCL
2026